A small pilot study has indicated that neurofeedback — where patients concentrate on modifying their own brainwave patterns — has potential to treat many of the 100m people worldwide who suffer from Treatment-Resistant Depression (TRD). This is the first time that neurofeedback has been shown to improve both individual symptoms and overall recovery in TRD.
According to the World Health Organisation, “Depression is the leading cause of disability worldwide,” with over 300m people suffering globally. There are treatments for depression, but up to a third of people don’t respond to treatment, even after trying different antidepressants. This is Treatment-resistant depression (TRD). For these patients, there are limited options.
Now a new pilot study from Korea indicates that neurofeedback may be offer a viable treatment to patients suffering from TRD, if used with antidepressants. Working with 12 patients with TRD and 12 controls, the researchers put patients through 12 weeks regular training sessions, where the patients learned how to vary their brainwaves in response to audio and visual signals.
Further work is needed to both replicate these results and compare this strategy with alternative treatment options (e.g. psychotherapy or additional pharmacotherapeutic steps). This will enable the community to determine where neurofeedback must be positioned and/or when it should be recommended in future guidelines.”
See the full story by clicking here.